肿瘤化疗辅助药物研究进展

[1] A randomized placebo-controlled trial of recombinant human interliukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Tepler I,Elias L,Smith JW,et al. Blood . 1996

[2] Amifostine pretreatment for protection against cyclophopha-mide-induced and cisplatin-induced toxicities: Results of a randomized control trail in patients with advanced ovarian cancer. Kemp G,Rose P,Lurain J,et al. Journal of Clinical Oncology . 1996

[3] A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma. Gebbia V,Testa A,Valenza R,et al. Journal of Chemotherapy . 1993

[4] Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. Gralla RJ,Navari RM,Hesketh PJ,et al. Journal of Clinical Oncology . 1998

[5] Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis. Navari R,Gandara D,Hesketh P,et al. Journal of Clinical Oncology . 1995

[6] Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Trillet Lenoir V,Green J,Manegold C,et al. European Journal of Cancer . 1993

[7] Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patient. Van Holten Verzantrvoort AT,Hermans J,Beex LV,et al. European Journal of Cancer . 1996

[8] Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17

[9] Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randimized parallel study. Perez EA,Hesketh P,Sandbach J,et al. Journal of Clinical Oncology . 1998

[10] Randomized, placebo controlled trial of filgrastim ( r-metHuG-CSF ) in patients with febrile neutropenia ( FN) following chemotherapy ( CT). Maher D,Green M,Bishop J,et al. Proceedings of the American Society of Clinical Oncology . 1993

[1] A randomized placebo-controlled trial of recombinant human interliukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Tepler I,Elias L,Smith JW,et al. Blood . 1996

[2] Amifostine pretreatment for protection against cyclophopha-mide-induced and cisplatin-induced toxicities: Results of a randomized control trail in patients with advanced ovarian cancer. Kemp G,Rose P,Lurain J,et al. Journal of Clinical Oncology . 1996

[3] A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma. Gebbia V,Testa A,Valenza R,et al. Journal of Chemotherapy . 1993

[4] Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. Gralla RJ,Navari RM,Hesketh PJ,et al. Journal of Clinical Oncology . 1998

[5] Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis. Navari R,Gandara D,Hesketh P,et al. Journal of Clinical Oncology . 1995

[6] Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Trillet Lenoir V,Green J,Manegold C,et al. European Journal of Cancer . 1993

[7] Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patient. Van Holten Verzantrvoort AT,Hermans J,Beex LV,et al. European Journal of Cancer . 1996

[8] Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17

[9] Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randimized parallel study. Perez EA,Hesketh P,Sandbach J,et al. Journal of Clinical Oncology . 1998

[10] Randomized, placebo controlled trial of filgrastim ( r-metHuG-CSF ) in patients with febrile neutropenia ( FN) following chemotherapy ( CT). Maher D,Green M,Bishop J,et al. Proceedings of the American Society of Clinical Oncology . 1993